小量创伤性气胸:观察与胸腔置管引流结局比较
该研究为单中心回顾性研究,纳入2016年1月1日至2020年12月31日该一级创伤中心初始胸片示气胸<30 mm、且排除损伤严重度评分≥25、需手术、血胸、双侧气胸及ICU入住的患者,按处理方式分为观察组(39例)与胸腔置管引流组(34例)。观察组住院时间显著短于置管组(3.6±0.33天 vs 5.8±0.81天,p<0.01);两组均无死亡与再入院。观察组1例因皮下气肿加重在18小时后改行胸腔置管,置管组1例发生脓胸。作者认为,对这类经筛选患者,先观察策略可能是更优的处理方式。
要点
- 初始胸片气胸<30 mm且无血胸、双侧气胸、ISS≥25、需手术或ICU入住的创伤患者,观察组住院时间3.6±0.33天 vs 置管组5.8±0.81天(p<0.01)。
- 观察组1例在18小时后因皮下气肿加重改行胸腔置管,提示观察期间需监测气胸及皮下气肿变化。
- 两组均无死亡、无再入院;置管组1例发生脓胸。
- CT上气胸大小与是否行胸腔置管相关,但多因素分析中仅胸腔置管与住院时间相关,胸片及CT气胸大小均不相关。
- 初始胸片气胸平均大小观察组18±1.0 mm vs 置管组18±0.84 mm(p>0.99),CT上为25±2.1 mm vs 37±3.9 mm(p=0.01)。
适用人群与场景
- 一级创伤中心收治的创伤患者,初始胸片气胸大小<30 mm(自肺尖至胸膜顶测量)。
- 排除损伤严重度评分≥25、需手术、血胸、双侧气胸及入住ICU的患者。
诊断标准与关键阈值
- 小量创伤性气胸定义:初始胸片(CXR)上自肺尖至胸膜顶测量气胸大小<30 mm。
处置流程与药物剂量
- 按处理策略分组:观察 vs 胸腔置管引流;观察组中1例因皮下气肿加重在18小时后改行胸腔置管。
红旗征与不能漏的情况
- 观察期间皮下气肿加重:观察组1例在18小时后因此改行胸腔置管。
研究设计与关键结果
- 单中心回顾性研究,2016年1月1日至2020年12月31日,观察组39例、胸腔置管组34例,两组基线特征相似。
- 初始胸片气胸平均大小:观察组18±1.0 mm vs 置管组18±0.84 mm(p>0.99);CT气胸平均大小:观察组25±2.1 mm vs 置管组37±3.9 mm(p=0.01)。
- 主要终点住院时间:观察组3.6±0.33天 vs 置管组5.8±0.81天,观察组显著缩短(p<0.01)。
- 多因素分析中仅胸腔置管与住院时间相关,CT气胸大小与胸腔置管相关,胸片及CT气胸大小均与住院时间不相关。
- 两组均无死亡、无再入院;观察组1例18小时后因皮下气肿加重改行胸腔置管,置管组1例发生脓胸。
证据类型、等级与局限
- 研究类型:单中心回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对初始胸片示小量创伤性气胸的经筛选患者,先观察策略可能是更优的处理方式;观察组平均住院时间较胸腔置管组缩短超过2天,其余结局相似。
- 适用人群为初始胸片气胸<30 mm且无ISS≥25、无手术需求、无血胸、无双侧气胸、未入住ICU的创伤患者;观察期间需留意皮下气肿加重等需改行胸腔置管的情况。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Traumatic pneumothorax management has evolved to include the use of smaller caliber tube thoracostomy and even observation alone. Data is limited comparing tube thoracostomy to observation for small traumatic pneumothoraces. We aimed to investigate whether observing patients with a small traumatic pneumothorax on initial chest radiograph (CXR) is associated with improved outcomes compared to tube thoracostomy.
METHODS: We retrospectively reviewed trauma patients at our level 1 trauma center from January 1, 2016 through December 31, 2020. We included those with a pneumothorax size <30 mm as measured from apex to cupola on initial CXR. We excluded patients with injury severity score ≥ 25, operative requirements, hemothorax, bilateral pneumothoraces, and intensive care unit admission. Patients were grouped by management strategy (observation vs tube thoracostomy). Our primary outcome was length of stay with secondary outcomes of pulmonary infection, failed trial of observation, readmission, and mortality. Results are listed as mean ± standard error of the mean.
RESULTS: Of patients who met criteria, 39 were in the observation group, and 34 were in the tube thoracostomy group. Baseline characteristics were similar between the groups. Average pneumothorax size on CXR was 18 ± 1.0 mm in the observation group and 18 ± 0.84 mm in the tube thoracostomy group (p > 0.99). Average pneumothorax sizes on computed tomography were 25 ± 2.1 and 37 ± 3.9 mm in the observation and tube thoracostomy groups, respectively (p = 0.01). Length of stay in the observation group was significantly shorter than the tube thoracostomy group (3.6 ± 0.33 vs 5.8 ± 0.81 days, p < 0.01). While pneumothorax size on computed tomography was associated with tube thoracostomy, only tube thoracostomy correlated with length of stay on multivariable analysis; pneumothorax size on CXR and computed tomography did not. There were no deaths or readmissions in either cohort. One patient in the observation group required tube thoracostomy after 18 h for worsening subcutaneous emphysema, and one patient in the tube thoracostomy group developed an empyema.
CONCLUSIONS: Select patients with small traumatic pneumothoraces on initial chest radiograph who were treated with observation experienced an average length of stay over two days shorter than those treated with tube thoracostomy. Outcomes were otherwise similar between the two groups suggesting that an observation-first strategy may be a superior treatment approach for these patients.
参考来源
- Banks KC, Mooney CM, Mazzolini K, et al. Comparison of outcomes between observation and tube thoracostomy for small traumatic pneumothoraces. Am J Emerg Med. 2023. PMID: 36680867. doi:10.1016/j.ajem.2023.01.017
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。